Literature DB >> 12821502

Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001.

Kevin C Katz1, Allison J McGeer, Carla L Duncan, Aisha Ashi-Sulaiman, Barbara M Willey, Alicia Sarabia, Jacquie McCann, Sylvia Pong-Porter, Yana Rzayev, Joyce S de Azavedo, Donald E Low.   

Abstract

Of 500 group A streptococci isolated from pharyngeal swabs, 72 (14.4%) were macrolide resistant, compared to 2.1% in 1997. Of these, 66 (92%) were of the M phenotype and 6 (8.3%) were of the MLS phenotype. Pulsed-field gel electrophoresis found that two clones, with patterns identical to those of serotypes M1 and M4, accounted for 19.4 and 68.1% of the macrolide-resistant isolates, respectively.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12821502      PMCID： PMC161827          DOI： 10.1128/AAC.47.7.2370-2372.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997.

Authors:  E L Kaplan; D R Johnson; M C Del Rosario; D L Horn
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

2.  Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?

Authors:  F Baquero
Journal:  J Chemother       Date:  1999-02       Impact factor: 1.714

3.  The role of efflux in macrolide resistance.

Authors:  Ping Zhong; Virginia D. Shortridge
Journal:  Drug Resist Updat       Date:  2000-12       Impact factor: 18.500

4.  Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America.

Authors:  Alan L Bisno; Michael A Gerber; Jack M Gwaltney; Edward L Kaplan; Richard H Schwartz
Journal:  Clin Infect Dis       Date:  2002-07-15       Impact factor: 9.079

5.  Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.

Authors:  M Pihlajamäki; P Kotilainen; T Kaurila; T Klaukka; E Palva; P Huovinen
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

6.  Erythromycin resistance in italian isolates of Streptococcus pyogenes and correlations with pulsed-field gel electrophoresis analysis.

Authors:  Claudia Zampaloni; Luca A Vitali; Manuela Prenna; Maria A Toscano; Gianna Tempera; Sandro Ripa
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

7.  Macrolide resistance among invasive Streptococcus pneumoniae isolates.

Authors:  T B Hyde; K Gay; D S Stephens; D J Vugia; M Pass; S Johnson; N L Barrett; W Schaffner; P R Cieslak; P S Maupin; E R Zell; J H Jorgensen; R R Facklam; C G Whitney
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

Review 8.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

9.  Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999.

Authors:  Ian A Critchley; Daniel F Sahm; Clyde Thornsberry; Renée S Blosser-Middleton; Mark E Jones; James A Karlowsky
Journal:  Diagn Microbiol Infect Dis       Date:  2002-02       Impact factor: 2.803

10.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191
View more
  13 in total

1.  Evolution and global dissemination of macrolide-resistant group A streptococci.

Authors:  D Ashley Robinson; Joyce A Sutcliffe; Wezenet Tewodros; Anand Manoharan; Debra E Bessen
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal.

Authors:  C Silva-Costa; M Ramirez; J Melo-Cristino
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting.

Authors:  Karen F McGregor; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002.

Authors:  Aleksandra K Wierzbowski; Dean Swedlo; Dave Boyd; Michael Mulvey; Kim A Nichol; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 5.  The use of macrolides in treatment of upper respiratory tract infections.

Authors:  Aleksandra K Wierzbowski; Daryl J Hoban; Tamiko Hisanaga; Mel DeCorby; George G Zhanel
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

Review 6.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

7.  Identification of group A streptococcal emm types commonly associated with invasive infections and antimicrobial resistance by the use of multiplex PCR and high-resolution melting analysis.

Authors:  P Bidet; S Liguori; C Plainvert; S Bonacorsi; C Courroux; C d'Humières; C Poyart; A Efstratiou; E Bingen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-20       Impact factor: 3.267

8.  The Use of Macrolides in Treatment of Upper Respiratory Tract Infections.

Authors:  Aleksandra K Wierzbowski; Daryl J Hoban; Tamiko Hisanaga; Mel Decorby; George G Zhanel
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

9.  DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci.

Authors:  T A Figueiredo; S I Aguiar; J Melo-Cristino; M Ramirez
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

10.  Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.

Authors:  Edouard Bingen; Philippe Bidet; Liliana Mihaila-Amrouche; Catherine Doit; Samuel Forcet; Naïma Brahimi; Anne Bouvet; Robert Cohen
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.